Clinical Trial Update: A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 study evaluating the safety and efficacy of LAE001 in metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• LAE001

Snippet

Sponsor: Laekna Limited | Conditions: Prostate Cancer Metastatic | Phase 1, Phase 2 | Status: TERMINATED